We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $697M
1-Year Est. Return 79.73%
This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$415M
AUM Growth
+$44.4M
Cap. Flow
+$47.9M
Cap. Flow %
11.55%
Top 10 Hldgs %
45.62%
Holding
96
New
27
Increased
21
Reduced
16
Closed
26

Top Buys

Rank Stock Value
1
WCG
Wellcare Health Plans, Inc.
WCG
+$11.3M
2
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$10.7M
3
LJPC
La Jolla Pharmaceutical Company
LJPC
+$9.88M
4
BEAT
BioTelemetry, Inc.
BEAT
+$8.09M
5
ELV icon
Elevance Health
ELV
+$8.01M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$18.6M
2
GILD icon
Gilead Sciences
GILD
+$16M
3
CVS icon
CVS Health
CVS
+$13.6M
4
ASND icon
Ascendis Pharma A/S
ASND
+$10.6M
5
NVO
Novo Nordisk
NVO
+$8.47M

Sector Composition

Rank Sector Weight
1 Healthcare 69.13%
2 Technology 1.01%
3 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UROV
51
DELISTED
Urovant Sciences Ltd.
UROV
$1.74M 0.42%
220,042
+5,000
+2% +$41K
LOGC
52
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$1.72M 0.42%
132,540
-26,418
-17% -$351K
PFNX
53
DELISTED
Pfenex Inc.
PFNX
$1.44M 0.35%
213,608
– –
ACHC icon
54
PUT
Acadia Healthcare
ACHC
$2.55B
$1.34M 0.32%
+38,400
New +$1.24M
CBIO
55
PUT
Crescent Biopharma
CBIO
$546M
$1.31M 0.32%
+1,101
New +$1.32M
WST icon
56
PUT
West Pharmaceutical
WST
$23.7B
$1.24M 0.3%
+9,900
New +$1.17M
ATNM icon
57
Actinium Pharmaceuticals
ATNM
$26.3M
$1.21M 0.29%
164,508
+153,181
+1,352% +$1.54M
SENS icon
58
Senseonics Holdings Inc
SENS
$254M
$1.13M 0.27%
27,743
– –
FRTX
59
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$1.13M 0.27%
4,221
-909
-18% -$305K
INGN icon
60
Inogen
INGN
$174M
$1.01M 0.24%
15,189
– –
ACHV icon
61
Achieve Life Sciences
ACHV
$634M
$1.01M 0.24%
26,221
+5,147
+24% +$364K
SVRA icon
62
PUT
Savara
SVRA
$1.08B
$982K 0.24%
+414,400
New +$3.68M
IMMU
63
DELISTED
Immunomedics Inc
IMMU
$971K 0.23%
+70,000
New +$1.05M
UBX
64
DELISTED
Unity Biotechnology
UBX
$956K 0.23%
+10,064
New +$856K
SVRA icon
65
Savara
SVRA
$1.08B
$948K 0.23%
+400,000
New +$3.55M
CCXI
66
CALL
DELISTED
ChemoCentryx, Inc.
CCXI
$930K 0.22%
+100,000
New +$1.16M
AFMD
67
DELISTED
Affimed
AFMD
$769K 0.19%
26,794
– –
AXSM icon
68
Axsome Therapeutics
AXSM
$11.7B
$523K 0.13%
20,310
-22,100
-52% -$443K
OCUL icon
69
Ocular Therapeutix
OCUL
$1.83B
$263K 0.06%
+59,668
New +$221K
BCRX icon
70
PUT
BioCryst Pharmaceuticals
BCRX
$2.42B
$147K 0.04%
+38,700
New +$233K
ASND icon
71
Ascendis Pharma A/S
ASND
$16.5B
– –
-90,325
Closed -$10.6M
BIIB icon
72
Biogen
BIIB
$30.9B
– –
-78,596
Closed -$18.6M
BPMC
73
DELISTED
Blueprint Medicines
BPMC
– –
-3,000
Closed -$240K
GILD icon
74
Gilead Sciences
GILD
$165B
– –
-245,968
Closed -$16M
GNFT
75
DELISTED
Genfit
GNFT
– –
-92,637
Closed -$2.22M
1 2
3
4

Similar funds

GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
KLI
Kelman-Lazarov Inc Memphis, Tennessee $698M AUM 14.07% 1-Year Est. Return
JA
JLB & Associates Plymouth, Michigan $696M AUM 17.86% 1-Year Est. Return
WIC
Wilkins Investment Counsel Boston, Massachusetts $698M AUM 17.36% 1-Year Est. Return
AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
TCM
Tensile Capital Management Larkspur, California $698M AUM 2.4% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return
SAM
Silverback Asset Management Chapel Hill, North Carolina $699M AUM 72.42% 1-Year Est. Return

Sio Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Sio Capital Management held 96 positions worth $415M, up 12% from $370M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Sio Capital Management deployed $47.9M of net new capital in Q2 2019, opening 27 new positions and adding to 21 existing holdings. Its largest new stake was La Jolla Pharmaceutical Company: 1,310,367 shares worth $12.1M.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, down from 81% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was CVS Health, an estimated $13.6M trimmed.

  • Sio Capital Management's largest Q2 2019 buy was La Jolla Pharmaceutical Company: 1,310,367 shares worth $12.1M.
  • Sio Capital Management added most to Wellcare Health Plans, Inc. in Q2 2019, an estimated $11.3M increase.
  • Sio Capital Management's biggest Q2 2019 reduction was CVS Health, cutting an estimated $13.6M.
  • Sio Capital Management fully exited Biogen in Q2 2019, selling an estimated $18.6M.
  • Sio Capital Management's ten largest holdings make up 46% of its $415M portfolio in Q2 2019.
  • Sio Capital Management opened 27 new positions and closed 26 in Q2 2019.
  • Sio Capital Management's portfolio value rose 12% quarter-over-quarter to $415M.

Based on Sio Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.